Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ying Huang, Weiji Lin, Zhe Chen, Yu Wang, Yao Huang & Shenghao Tu. (2019) Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon?. Drug Design, Development and Therapy 13, pages 2111-2125.
Read now
Read now
Juan Chen, Shuhong Chi, Feng Li, Jiali Yang, William C. Cho & Xiaoming Liu. (2017) Biologics-induced interstitial lung diseases in rheumatic patients: facts and controversies. Expert Opinion on Biological Therapy 17:3, pages 265-283.
Read now
Read now
Masahito Koiwa, Susumu Goto, Kenji Takenouchi, Kenji Takahasi, Toshikazu Kamada & Hiroshi Nakamura. (2012) Elevation of serum KL-6 levels in 3 patients with rheumatoid arthritis treated with adalimumab. Modern Rheumatology 22:1, pages 147-151.
Read now
Read now
Isamu Cho, Shunsuke Mori, Fumiya Imamura, Chikage Kiyofuji & Mineharu Sugimoto. (2007) Methotrexate pneumonia lacking dyspnea and radiographic interstitial patterns during treatment for early rheumatoid arthritis: bronchoalveolar lavage and transbronchial lung biopsy in a differential diagnosis. Modern Rheumatology 17:3, pages 256-261.
Read now
Read now
Shunsuke Mori. (2007) A relationship between pharmacokinetics (PK) and the efficacy of infliximab for patients with rheumatoid arthritis: characterization of infliximab-resistant cases and PK-based modified therapy. Modern Rheumatology 17:2, pages 83-91.
Read now
Read now
Articles from other publishers (14)
Stanley Chioma, Samiran Mukherjee, Kanish Mirchia, Prateek S. Harne & Harvir Singh Gambhir. (2022) Infliximab-Associated Pneumonitis Treated With Corticosteroids. American Journal of Therapeutics 29:6, pages e727-e729.
Crossref
Crossref
Theodoros Karampitsakos, Argyro Vraka, Demosthenes Bouros, Stamatis-Nick Liossis & Argyris Tzouvelekis. (2019) Biologic Treatments in Interstitial Lung Diseases. Frontiers in Medicine 6.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
73
97
.
Kundan Iqbal & Clive Kelly. (2015) Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review. Therapeutic Advances in Musculoskeletal Disease 7:6, pages 247-267.
Crossref
Crossref
Shunsuke Mori. (2015) Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 9s1, pages CCRPM.S23288.
Crossref
Crossref
Dave Nicholls, Jane Zochling, Anthony Boers, Gary Champion, David Mathers, John Riordan, Peter Youssef, James Scott & Hedley Griffiths. (2013)
A retrospective chart review of the use of rituximab for the treatment of rheumatoid arthritis in
A
ustralian rheumatology practice
. International Journal of Rheumatic Diseases 17:7, pages 755-761.
Crossref
Crossref
Camille Roubille & Boulos Haraoui. (2014) Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: A systematic literature review. Seminars in Arthritis and Rheumatism 43:5, pages 613-626.
Crossref
Crossref
Soumitra Sen, Kim Jordan, Thomas J. Boes & Carrie Peltz. (2012) Infliximab-Induced Nonspecific Interstitial Pneumonia. The American Journal of the Medical Sciences 344:1, pages 75-78.
Crossref
Crossref
. 2010. Meyler's Side Effects of Analgesics and Anti-inflammatory Drugs. Meyler's Side Effects of Analgesics and Anti-inflammatory Drugs
371
667
.
Hirofumi Taki, Yukio Kawagishi, Koichiro Shinoda, Hiroyuki Hounoki, Reina Ogawa, Eiji Sugiyama & Kazuyuki Tobe. (2009) Interstitial pneumonitis associated with infliximab therapy without methotrexate treatment. Rheumatology International 30:2, pages 275-276.
Crossref
Crossref
Johan Askling & Will Dixon. (2008) The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis. Current Opinion in Internal Medicine 7:3, pages 301-307.
Crossref
Crossref
Johan Askling & Will Dixon. (2008) The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis. Current Opinion in Rheumatology 20:2, pages 138-144.
Crossref
Crossref
Isamu Cho, Shunsuke Mori, Fumiya Imamura, Chikage Kiyofuji & Mineharu Sugimoto. (2007) Methotrexate pneumonia lacking dyspnea and radiographic interstitial patterns during treatment for early rheumatoid arthritis: bronchoalveolar lavage and transbronchial lung biopsy in a differential diagnosis. Modern Rheumatology 17:3, pages 256-261.
Crossref
Crossref
Shunsuke Mori. (2007) A relationship between pharmacokinetics (PK) and the efficacy of infliximab for patients with rheumatoid arthritis: characterization of infliximab-resistant cases and PK-based modified therapy. Modern Rheumatology 17:2, pages 83-91.
Crossref
Crossref